These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17468301)

  • 1. Tolerance to the antinociceptive and antiexudative effects of morphine in a murine model of peripheral inflammation.
    Fernández-Dueñas V; Pol O; García-Nogales P; Hernández L; Planas E; Puig MM
    J Pharmacol Exp Ther; 2007 Jul; 322(1):360-8. PubMed ID: 17468301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiexudative effects of opioids and expression of kappa- and delta-opioid receptors during intestinal inflammation in mice: involvement of nitric oxide.
    Jiménez N; Puig MM; Pol O
    J Pharmacol Exp Ther; 2006 Jan; 316(1):261-70. PubMed ID: 16183704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain.
    Yamamoto J; Kawamata T; Niiyama Y; Omote K; Namiki A
    Neuroscience; 2008 Feb; 151(3):843-53. PubMed ID: 18178319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a state of pain.
    Imai S; Narita M; Hashimoto S; Nakamura A; Miyoshi K; Nozaki H; Hareyama N; Takagi T; Suzuki M; Narita M; Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):183-92. PubMed ID: 17240843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain.
    Leánez S; Hervera A; Pol O
    Eur J Pharmacol; 2009 Jan; 602(1):41-9. PubMed ID: 19041302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic inflammation and morphine tolerance on the expression of phospho-ERK 1/2 and phospho-P38 in the injured tissue.
    Almela P; García-Nogales P; Romero A; Milanés MV; Laorden ML; Puig MM
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):315-23. PubMed ID: 18839150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats.
    Cook CD; Nickerson MD
    J Pharmacol Exp Ther; 2005 Apr; 313(1):449-59. PubMed ID: 15608071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction.
    Puehler W; Zöllner C; Brack A; Shaqura MA; Krause H; Schäfer M; Stein C
    Neuroscience; 2004; 129(2):473-9. PubMed ID: 15501604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the inducible nitric oxide synthase gene reduces peripheral morphine tolerance in a mouse model of chronic inflammation.
    Romero A; Hernández L; García-Nogales P; Puig MM
    Fundam Clin Pharmacol; 2010 Jun; 24(3):317-23. PubMed ID: 19751225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression.
    Brack A; Rittner HL; Machelska H; Shaqura M; Mousa SA; Labuz D; Zöllner C; Schäfer M; Stein C
    Pain; 2004 Mar; 108(1-2):67-75. PubMed ID: 15109509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to the antinociceptive effects of peripherally administered opioids. Expression of beta-arrestins.
    Hernández L; Romero A; Almela P; García-Nogales P; Laorden ML; Puig MM
    Brain Res; 2009 Jan; 1248():31-9. PubMed ID: 19026993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties.
    Tzschentke TM; Christoph T; Kögel B; Schiene K; Hennies HH; Englberger W; Haurand M; Jahnel U; Cremers TI; Friderichs E; De Vry J
    J Pharmacol Exp Ther; 2007 Oct; 323(1):265-76. PubMed ID: 17656655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of lornoxicam in rats with paw inflammation.
    Futaki N; Harada M; Sugimoto M; Hashimoto Y; Honma Y; Arai I; Nakaike S; Hoshi K
    J Pharm Pharmacol; 2009 May; 61(5):607-14. PubMed ID: 19405999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of adrenomedullin in the spinal cord and dorsal root ganglia in the early phase of CFA-induced inflammation in rats.
    Hong Y; Liu Y; Chabot JG; Fournier A; Quirion R
    Pain; 2009 Nov; 146(1-2):105-13. PubMed ID: 19683388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
    Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
    Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin-transporter.
    Palm F; Mössner R; Chen Y; He L; Gerlach M; Bischofs S; Riederer P; Lesch KP; Sommer C
    Eur J Pain; 2008 Aug; 12(6):790-7. PubMed ID: 18187350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential involvement of μ-opioid receptor dysregulation on the reduced antinociception of morphine in the inflammatory pain state in mice.
    Aoki Y; Mizoguchi H; Watanabe C; Takeda K; Sakurada T; Sakurada S
    J Pharmacol Sci; 2014; 124(2):258-66. PubMed ID: 24553404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal mu-opioid receptor expression and hyperalgesia with dexamethasone in chronic adjuvant-induced arthritis in rats.
    Zaringhalam J; Manaheji H; Mghsoodi N; Farokhi B; Mirzaiee V
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1309-15. PubMed ID: 18671722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.